Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2011
11/10/2011US20110275569 Proteases targeting agents
11/10/2011US20110275564 Erythropoietin
11/10/2011US20110275534 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform
11/10/2011US20110275150 Compstatin analogs with improved activity
11/10/2011US20110275135 Genetic elements, proteins, and associated methods including application of additional genetic information to gram (+) thermoacidophiles
11/10/2011US20110275126 Method for Producing Nucleic Acid Sample and Method for Producing Nucleic Acid Amplification Product Using the Same
11/10/2011US20110275122 Thrombopoietic compounds
11/10/2011US20110275120 Fusion Proteins With Cleavable Spacers and Uses Thereof
11/10/2011US20110275107 Long wavelength engineered fluorescent proteins
11/10/2011US20110275081 Biomarker for diagnosis of canine cancer
11/10/2011US20110275077 Oligonucleotide-Coated Affinity Membranes and Uses Thereof
11/10/2011US20110275071 Methods and Reagents for Combined PCR Amplification
11/10/2011US20110275070 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
11/10/2011US20110275059 Diagnostic Transcript and Splice Patterns of HR-HPV in Different Cervical Lesions
11/10/2011US20110274930 Method for polymerizing a small oligonucleotide, and use of a high-molecular oligonucleotide prepared by the polymerization method
11/10/2011US20110274747 C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)
11/10/2011US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
11/10/2011US20110274711 Hla-g polypeptides and pharmaceutical uses thereof
11/10/2011US20110274709 T-Cell Immunogens Derived from Anti-Viral Proteins and Methods of Using Same
11/10/2011US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
11/10/2011US20110274707 Composition for improving inflammatory disease using abh antigens
11/10/2011US20110274702 Neutralizing anti-influenza a virus antibodies and uses thereof
11/10/2011US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011US20110274696 Antibodies to ccr2
11/10/2011US20110274692 Screening Methods
11/10/2011US20110274691 Ferroportin antibodies and methods of use
11/10/2011US20110274690 Compositions and methods for the diagnosis and treatment of tumor
11/10/2011US20110274683 Antibodies That Bind CSF1R
11/10/2011US20110274681 Human e3alpha ubiquitin ligase family
11/10/2011US20110274669 Therapeutic retroviral vectors for gene therapy
11/10/2011US20110274658 Chimeric activators: quantitatively designed protein therapeutics and uses thereof
11/10/2011US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/09/2011EP2385144A1 Amplification and detection reagents for HIV-1
11/09/2011EP2385104A1 Variant Scytalidium thermophilium CBH1
11/09/2011EP2385103A2 Variant Hypocrea jecorina CBH1
11/09/2011EP2385056A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
11/09/2011EP2384767A1 Antibodies that bind OV064 and methods of use therefor
11/09/2011EP1660654B1 Expression vector
11/09/2011EP1420631B1 Plant-derived resistance gene
11/09/2011CN1555414B Plant-derived resistance gene
11/09/2011CN102234334A Immunoglobulin chimeric monomer - dimer heterozygote
11/09/2011CN101830998B Method for extracting ribonucleic acid and cell wall polysaccharides in single cell protein by using one-step method
11/08/2011US8053647 Plants and seeds of corn variety CV006790
11/08/2011US8053639 Hydroxyproline-rich glycoprotein promoter
11/08/2011US8053633 Fungal desaturases and related methods
11/08/2011US8053630 Nematode inducible plant metabolite exporter gene promoters
11/08/2011US8053569 Nucleic acids encoding and methods of producing fusion proteins
11/08/2011US8053568 Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof
11/08/2011US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011US8053422 Anti-cancer oligodeoxynucleotides
11/08/2011US8053420 Enhance cellular uptake of uncharged antisense oligonucleotide; forming a conjugate and arginine-rich peptide; oligonucleotide includes a string of contiguous guanine bases; substitute inosine base to limit the number of contiguous guanine bases to three; cancer, polycystic kidney disease, restenosis
11/08/2011US8053237 Plant cell signaling genes
11/08/2011US8053231 Expression vector comprising nucleotide sequences coding inflammatory cytokine for use in prevention and treatment of inflammatory disorders
11/08/2011US8053224 Glucose-induced inactivation/degradation-resistant transporter gene and use thereof
11/08/2011US8053222 Protein expression system involving mutated severe respiratory syndrome-associated coronavirus 3C-like protease
11/08/2011US8053213 Detection of PCR products in gel electrophoresis
11/08/2011US8053195 Isolated genomic nucleic acid molecules obtainable from chromosome 1p21-p13 that encode human RhoC
11/08/2011US8053191 Iterative nucleic acid assembly using activation of vector-encoded traits
11/08/2011US8053189 Method for the diagnosis of colorectal cancer
11/08/2011US8053188 Using nuclease digestion of unprotected nucleotide sequences to select for and amplify preferential polynucleotides; for use in population genetics, identification of lineage in plant and animal breeding and in analysis of microorganisms
11/08/2011US8053187 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
11/08/2011US8053184 Soybean event MON89788 and methods for detection thereof
11/08/2011US8053183 Method of diagnosing esophageal cancer
11/08/2011US8053182 Predictors of transplant rejection determined by peripheral blood gene-expression profiling
11/08/2011US8052979 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
11/08/2011US8052966 gene therapy; producing targeted viral and non-viral particles delivery vectors for treating neoplastic disorders; retroviral, adenoviral, adeno-associated virus, Herpes Virus, and pseudotyped viruses, vesicular stomatitis virus G-protein (VSV-G), and to non-viral vectors that contain a viral protein
11/08/2011CA2653201C Compositions and uses of e3-gp19k for treating diabetes
11/08/2011CA2452205C Activators for oligonucleotide synthesis
11/08/2011CA2247285C Human tumor necrosis factor delta and epsilon
11/08/2011CA2167354C Oligonucleotides for the detection of salmonella
11/03/2011WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses
11/03/2011WO2011136743A1 Methods and/or primers for the detection of influenza a
11/03/2011WO2011134643A1 Improved glycosylation of proteins in host cells
11/03/2011WO2004039831A3 Peptide nucleic acid probes for analysis of enterococcus faecium
11/03/2011US20110271408 Modified pyr/pyl receptors activated by orthogonal ligands
11/03/2011US20110271407 Polypeptides Having Alpha-Mannosidase Activity And Polynucleotides Encoding Same
11/03/2011US20110271404 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
11/03/2011US20110271396 Chimeric Compositions and Methods for Regulating Plant Gene Expresssion
11/03/2011US20110271358 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
11/03/2011US20110271357 Colon disease targets and uses thereof
11/03/2011US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011US20110269951 siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
11/03/2011US20110269950 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
11/03/2011US20110269949 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
11/03/2011US20110269948 Method for Identifying Compounds for Cancer Therapy
11/03/2011US20110269940 Self-Assembled Proteins and Related Methods and Protein Structures
11/03/2011US20110269937 Conserved-Element Vaccines and Methods for Designing Conserved-Element Vaccines
11/03/2011US20110269825 Modified Thromboxane A2 Receptor Promoter Sequence
11/03/2011US20110269823 Compositions And Methods For Inhibiting Expression Of The HAMP Gene
11/03/2011US20110269821 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
11/03/2011US20110269820 Spinal muscular atrophy treatment via targeting smn2 catalytic core
11/03/2011US20110269818 Modulation of prion expression
11/03/2011US20110269816 Inhibition of Viral Gene Expression Using Small Interfering RNA
11/03/2011US20110269815 Methods of reducing cellular proliferation by inhibiting acsvl3
11/03/2011US20110269814 2'-f modified rna interference agents
11/03/2011US20110269735 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
11/03/2011US20110269707 Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
11/03/2011US20110269688 Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
11/03/2011US20110269687 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
11/03/2011US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses